Sorafenib (Bay 43-9006)

DRUG2 trials

Sponsors

Mt. Sinai Medical Center, Miami, Italian Trial in Medical Oncology

Conditions

Hepatocellular CarcinomaMalignant Melanoma

Phase 2

A Phase II Trial OF Carboplatin, ABI-007 (Abraxane) And Sorafenib (BAY 43-9006) in Metastatic Melanoma

CompletedNCT00483301

Mt. Sinai Medical Center, MiamiMalignant Melanoma

Start: 2007-05-31End: 2009-08-31Updated: 2012-05-03

Study of Sorafenib and Infusional 5-Fluorouracil in Advanced Hepatocellular Carcinoma (HCC)

CompletedNCT00619541

Italian Trial in Medical OncologyHepatocellular Carcinoma

Start: 2007-01-31End: 2009-01-31Target: 46Updated: 2009-02-26